Invesco Ltd. - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 45 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2018$14,029,000
+0.9%
15,000,0000.0%0.00%
-20.0%
Q2 2018$13,903,000
+5.8%
15,000,0000.0%0.01%0.0%
Q1 2018$13,147,000
-0.1%
15,000,0000.0%0.01%0.0%
Q4 2017$13,163,000
-2.6%
15,000,0000.0%0.01%0.0%
Q3 2017$13,519,000
-16.0%
15,000,0000.0%0.01%0.0%
Q2 2017$16,088,000
-0.1%
15,000,0000.0%0.01%0.0%
Q1 2017$16,106,000
-1.9%
15,000,0000.0%0.01%
-16.7%
Q4 2016$16,425,000
-8.2%
15,000,0000.0%0.01%0.0%
Q3 2016$17,897,000
+9.9%
15,000,000
+15.4%
0.01%0.0%
Q2 2016$16,291,000
-3.7%
13,000,0000.0%0.01%
-14.3%
Q1 2016$16,916,000
-16.7%
13,000,0000.0%0.01%
-12.5%
Q4 2015$20,296,000
+15.1%
13,000,0000.0%0.01%
+14.3%
Q3 2015$17,631,000
-3.0%
13,000,0000.0%0.01%0.0%
Q2 2015$18,168,000
-29.9%
13,000,000
-25.7%
0.01%
-30.0%
Q1 2015$25,900,000
+8.3%
17,500,0000.0%0.01%
+11.1%
Q4 2014$23,909,000
+6.4%
17,500,0000.0%0.01%0.0%
Q3 2014$22,466,000
-12.1%
17,500,000
-12.5%
0.01%
-10.0%
Q2 2014$25,563,000
-28.1%
20,000,000
-28.6%
0.01%
-28.6%
Q1 2014$35,543,000
+19.5%
28,000,0000.0%0.01%
+16.7%
Q4 2013$29,733,000
+2.4%
28,000,0000.0%0.01%
-7.7%
Q3 2013$29,033,000
-1.0%
28,000,0000.0%0.01%
-7.1%
Q2 2013$29,330,00028,000,0000.01%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2016
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders